Genentech to Present Late-Stage Cancer Data at ESMO 2026
Genentech says it will present new data, including two late-breaking abstracts, across lung, breast and other cancers at the ESMO annual meeting in Madrid from October 23 to 27.
Genentech says it will present new data, including two late-breaking abstracts, across lung, breast and other cancers at the ESMO annual meeting in Madrid from October 23 to 27.